Cosmos Health Inc. (COSM)
(Delayed Data from NSDQ)
$0.81 USD
-0.01 (-0.91%)
Updated Oct 18, 2024 11:31 AM ET
4-Sell of 5 4
D Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Cosmos Health Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 53 | 50 | 56 | 55 | 40 |
Cost Of Goods | 49 | 44 | 48 | 47 | 36 |
Gross Profit | 4 | 6 | 8 | 8 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 26 | 13 | 13 | 5 | 4 |
Income After Depreciation & Amortization | -22 | -7 | -5 | 3 | 0 |
Non-Operating Income | 4 | -2 | 0 | 1 | -1 |
Interest Expense | 1 | 4 | 4 | 3 | 2 |
Pretax Income | -19 | -13 | -8 | 1 | -3 |
Income Taxes | 0 | 1 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -14 | -8 | 1 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -19 | -14 | -8 | 1 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -21 | -6 | -3 | 3 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 1 | 0 | 1 |
Income After Depreciation & Amortization | -22 | -7 | -5 | 3 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 11.97 | 1.93 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.67 | -33.22 | NA | NA | NA |
Diluted Net EPS (GAAP) | -2.15 | -33.16 | -23.75 | 1.50 | -6.25 |
Fiscal Year end for Cosmos Health Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 13.21 | 14.58 | 15.84 | 12.82 |
Cost Of Goods | NA | 12.44 | 13.25 | 14.61 | 11.61 |
Gross Profit | NA | 0.77 | 1.33 | 1.23 | 1.21 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.27 | 3.17 | 14.82 | 4.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.50 | -1.84 | -13.59 | -3.02 |
Non-Operating Income | NA | 0.25 | 0.14 | 0.17 | -0.25 |
Interest Expense | NA | 0.34 | 0.17 | 0.34 | 0.15 |
Pretax Income | NA | -2.59 | -1.87 | -13.75 | -3.42 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | -0.07 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.59 | -1.87 | -13.75 | -3.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.59 | -1.87 | -13.75 | -3.35 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 17.83 | 16.85 | 12.13 | 12.59 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.04 | 0.10 | -0.09 |
Diluted Net EPS (GAAP) | NA | -0.15 | -0.11 | -1.75 | -0.27 |